Mankind Pharma Limited — QIP/Rights/Pref., 19-12-2024: Qualified Institutional Placement

Mankind Pharma has announced a Qualified Institutions Placement (QIP) of equity shares, successfully raising ₹2,992.07 crore through the allocation of 1,19,04,761 equity shares at an issue price of ₹2,520 each. This price reflects a 3.69% discount to the floor price. The issue period closed on the same day, after receiving applications and funds from qualified institutional buyers. The placement document has been adopted and will be available on the company’s website, while confirmation notes will be sent to the buyers regarding their allocations.